title: Time course toxicogenomic profiles in CD-1 mice after nontoxic and nonlethal hepatotoxic paracetamol administration.
abstract: Adverse drug reactions are a major clinical problem. Drug-induced hepatotoxicity constitutes a large percentage of these reactions. A thorough understanding of the genetic events, specifically, the early "decision-making" processes underlying biological changes caused by drugs and metabolites, is required. To assist in the understanding of these events, we have employed the model hepatotoxin, paracetamol (APAP), and GeneChip technology to investigate global genetic events seen after nontoxic and toxic doses in the mouse. Mice were dosed [vehicle, nontoxic APAP (1 mmol/kg), and toxic APAP (3.5 mmol/kg)], and individual hepatic RNA samples were hybridized to separate chips to determine interanimal variation. Statistical analysis detected 175 CD-1 mouse genes that were significantly regulated (P < 4.1 x 10(-6)), and nonsignificant genes were discarded. For clarity, the significantly regulated genes were then binned into categories according to their major function-antioxidant, glutathione, metabolism, transcription, immune, and apoptosis. There was no hepatic stress observed after dosing 1 mmol/kg APAP, when measured by serum alanine aminotransferase levels. Hepatic toxicity was observed at both 4 and 24 h after a 3.5 mmol/kg dose of APAP. Time course expression profiles for selected genes have been created. These results demonstrate that most active gene expression occurs around 4 h after a toxic dose of APAP. Down-regulation of these genes is observed over 24 h, coinciding with the development of overt toxicity. These data provide a deeper understanding of the in vivo time course of physiological responses of the liver to chemical stress and provide a logical step forward for the investigation of new chemical entities demonstrated positive in chemically reactive metabolite screens. The complete data set can be viewed at http://www.ebi.ac.uk/arrayexpress/. The accession number is E-MEXP-82.
authors.affiliation: Department of Pharmacology and Therapeutics, University of Liverpool, Sherrington Building, Ashton Street, P.O. Box 147, Liverpool, Merseyside L69 3GE, United Kingdom. dom@liv.ac.uk
authors.forename: D P
authors.initials: DP
authors.lastname: Williams
authors.forename: C
authors.initials: C
authors.lastname: Garcia-Allan
authors.forename: G
authors.initials: G
authors.lastname: Hanton
authors.forename: J L
authors.initials: JL
authors.lastname: LeNet
authors.forename: J P
authors.initials: JP
authors.lastname: Provost
authors.forename: P
authors.initials: P
authors.lastname: Brain
authors.forename: R
authors.initials: R
authors.lastname: Walsh
authors.forename: G I
authors.initials: GI
authors.lastname: Johnston
authors.forename: D A
authors.initials: DA
authors.lastname: Smith
authors.forename: B K
authors.initials: BK
authors.lastname: Park
mesh_terms: D000082:Acetaminophen / Q000494:pharmacology / Q000633:toxicity*; D000818:Animals; D004151:Dipeptides / Q000235:genetics; D015536:Down-Regulation; D015870:Gene Expression / Q000187:drug effects*; D020869:Gene Expression Profiling; D006360:Heat-Shock Proteins / Q000235:genetics; D008099:Liver / Q000187:drug effects* / Q000201:enzymology; D008297:Male; D051379:Mice; D013997:Time Factors; D015854:Up-Regulation
chemical_list: D004151:Dipeptides; D006360:Heat-Shock Proteins; D000082:Acetaminophen; C017341:gamma-glutamylcysteine